Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Pulmonary Pharmacology & Therapeutics|December 7, 2007
The role of collagenases in experimental pulmonary fibrosisHiroshi Ouchi, Masaki Fujita, Satoshi Ikegame, et al.Cytokine|October 8, 2008
TNF receptor 1 and 2 contribute in different ways to resistance to Legionella pneumophila-induced mortality in miceMasaki Fujita, Satoshi Ikegame, Eiji Harada, et al.Respiration; International Review of Thoracic Diseases|October 7, 2004
Serum CC-10 in inflammatory lung diseasesQing Ye, Masaki Fujita, Hiroshi Ouchi, et al.Cytokine|January 22, 2008
Attenuation of pulmonary hypertension, but not emphysematous change, by breeding emphysema model mice at sea levelMasaki Fujita, Satoshi Ikegame, Qing Ye, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 22, 2012
The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergillomaMasaki Fujita, Yoshiaki Tao, Akira Kajiki, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 5, 2010
Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancerMasaki Fujita, Hiroshi Ouchi, Yuichi Inoue, et al.Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|January 12, 2010
[A case of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome, complicated with disseminated M. abscessus infection]Yukari Asai, Hiroshi Ouchi, Tukasa Ohosima, et al.Pulmonary Pharmacology & Therapeutics|July 29, 2008
Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosisMasaki Fujita, Yuichi Mizuta, Satoshi Ikegame, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 20, 2011
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC diseaseMasaki Fujita, Akira Kajiki, Yoshiaki Tao, et al.Anticancer Research|February 4, 2019
Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung CancerNaoki Kubo, Taishi Harada, Yoshimasa Shiraishi, et al.Pageof 3